Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 10,821–10,840 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass II

TRI MIX 11.8/17.6/0.59 5ML MDV MCG/MG/MG/ML INJ, Injection, 11.8mcg/17.6mg/0.59mg/mL, Rx only, 5mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 10/30/1 5ML MDV MCG/MG/MG/ML INJ, Injection, 10mcg/30mg/1mg/mL, Rx only, 5 mL Glass/ Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 10/30/0.5 *5ML* MDV MCG/MG/MG/ML INJ, Injection,10mcg/30mg/0.5mg/mL, Rx only, 5 mL Glass/ Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 10/15/2.5 5ML MDV MCG/MG/MG/ML INJ, Injection, 10mcg/15mg/2.5mg/mL, Rx only, 5 mL Glass/ Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 10/15/1 5ML MDV MCG/MG/MG/ML INJ, Injection, 10mcg/15mg/1mg/mL, Rx only, 5 mL Glass/ Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

PGE1/PAP 10/30 5ML MDV MCG/MG/ML INJ, Injection, 10mg/30mg/mL, Rx only, 5mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

PGE1/CPZ 5ML MDV 20MCG/1MG/ML INJ, Injection, 20mcg/1mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

PGE1 5ML MDV INJ, Injection, 40mcg/mL, Rx only, 5mL glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

PGE1 MDV 20MCG/ML INJ, Injection, 20mcg/mL, Rx only, packaged in a 5 mL, 10mL, and 15 mL Glass/Multiple Dose vials, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE/PHENT 5ML MDV 30/1MG/ML INJ, Injection, 30mg/1mg/mL, Rx only, 5mL glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE/PHENT 5ML MDV 30/0.5MG/ML INJ, Injection, 30/0.5mg/mL, Rx only, 5mL glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

HYDROXO-B12 5ML PBF MDV (CALIF) 10MG/ML INJ, Injection, 10mg/mL, RX only, 5mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

HYDROXO-B12 PBF MDV 10MG/ML INJ, Injection, 10mg/mL, Rx only, packaged in a 5 mL and 30 mL Glass/ Multiple Dose vials, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

HYDROXO-B12 30ML PBF MDV (CALIF) 1MG/ML INJ, Injection, 1mg/mL, Rx only, 30 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

HYDROXO-B12 5ML PBF MDV 1MG/ML INJ, Injection, 1mg/ml, Rx only, packaged in 5 mL Glass/ Multiple Dose and 30 mL Glass/ Multiple Dose vials,Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

HYDROXO-B12 10ML PBF MDV 5MG/ML INJ, 5mg/mL, Rx only, 10 mL Glass/ Multiple Dose vial, Prepared by Key Compounding Pharmacy HYDROXO-B12 30ML PBF MDV 5MG/ML INJ, 5mg/mL, RX only, 30 mL Glass/ Multiple Dose vial.

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

HYDROXO-B12 INH PF GV 5MG/ML SOLN, Inhalation Solution, 5mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

HYDROXO-B12 1ML SDV 10MG/ML INJ, Injection, 10mg/mL, Rx only, 1 mL glass/ Single Dose vial, Prepared by Key Compounding Pharmacy HYDROXO-B12 2ML SDV 10MG/ML INJ, Injection, 10mg/mL, RX only, 2 mL glass/ Single Dose vial.

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

HYDROXO-B12 *1ML* SDV 1MG/ML INJ, Injection, 1mg/mL, Rx only, 1 mL Glass/Single Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

HCG *10ML* MDV 500U/ML INJ, Injection, 500u/mL, Rx only, 10 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.